首页> 美国卫生研究院文献>Experimental and Therapeutic Medicine >CCAAT/enhancer binding protein homologous protein knockdown alleviates hypoxia-induced myocardial injury in rat cardiomyocytes exposed to high glucose
【2h】

CCAAT/enhancer binding protein homologous protein knockdown alleviates hypoxia-induced myocardial injury in rat cardiomyocytes exposed to high glucose

机译:CCAAT /增强子结合蛋白同源蛋白敲低减轻低氧诱导的高糖暴露大鼠心肌细胞的心肌损伤

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Diabetic patients are more sensitive to ischemic injury than non-diabetics. Endoplasmic reticulum (ER) stress has been reported to be closely associated with the pathophysiology of ischemic injury in diabetes. The aim of the present study was to investigate the mechanisms involved in the progression of diabetes complicated by myocardial infarction (MI) and further verify the role of CCAAT/enhancer binding protein (C/EBP)-homologous protein (CHOP) using an in vitro model of diabetes/MI. The rats were exposed to 65 mg/kg streptozotocin (STZ) and left anterior descending (LAD) coronary artery ligation. ST-segment elevation, heart rate, left ventricular systolic pressure (LVSP) and LV end-diastolic pressure (LVEDP) were measured. Serum creatinine kinase-MB (CK-MB) and cardiac troponin T (cTnT) levels were examined by ELISA. Infarct size and apoptosis were measured by triphenyltetrazolium chloride staining and terminal deoxynucleotidyl-transferase-mediated dUTP nick end labeling assay. Pathological changes were evaluated by hematoxylin and eosin staining. H9c2 cells were used to establish an in vitro model of diabetes complicated by MI. Following CHOP knockdown, cell viability, cell cycle distribution and apoptosis were examined by Cell Counting Kit-8 assay, flow cytometry and Hoechst staining. Glucose-regulated protein 78 (GRP78), CHOP, B-cell lymphoma 2 (Bcl-2), Bcl-2-associated X protein (Bax), endoplasmic reticulum oxidoreductase 1 (Ero1)-α, Ero1β and protein disulfide isomerase (PDI) levels in both myocardial tissues and H9c2 cells were determined by western blotting. In the present study, diabetes complicated by MI promoted ST-segment elevation and myocardial apoptosis, increased infarct size, induced pathological changes and elevated LVEDP, CK-MB, cTnT, GRP78, CHOP, Bax, Ero1α, Ero1β and PDI; however, it decreased heart rate, LVSP and Bcl-2. Additionally, high glucose combined with hypoxic treatment reduced cell viability, induced cell cycle arrest at G1 phase, promoted cell apoptosis, and activated the GRP78/CHOP and Ero1/PDI signaling pathways, which were reversed by CHOP knockdown. Thus, CHOP may be an effective therapeutic target for the treatment of diabetes complicated by MI.
机译:糖尿病患者比非糖尿病患者对缺血性损伤更为敏感。据报道,内质网应激与糖尿病缺血性损伤的病理生理密切相关。本研究的目的是探讨与糖尿病并发心肌梗塞(MI)的进展有关的机制,并进一步使用体外验证CCAAT /增强子结合蛋白(C / EBP)-同源蛋白(CHOP)的作用糖尿病/心梗的模型。大鼠暴露于65 mg / kg链脲佐菌素(STZ),并结扎左前降支(LAD)。测量ST段抬高,心率,左心室收缩压(LVSP)和LV舒张末期压(LVEDP)。 ELISA检测血清肌酐激酶-MB(CK-MB)和心肌肌钙蛋白T(cTnT)水平。通过氯化三苯四唑和末端脱氧核苷酸转移酶介导的dUTP缺口末端标记测定法测定梗塞面积和凋亡。通过苏木精和曙红染色评估病理变化。 H9c2细胞用于建立糖尿病并发MI的体外模型。 CHOP敲低后,通过Cell Counting Kit-8分析,流式细胞术和Hoechst染色检查细胞活力,细胞周期分布和凋亡。葡萄糖调节蛋白78(GRP78),CHOP,B细胞淋巴瘤2(Bcl-2),Bcl-2相关X蛋白(Bax),内质网氧化还原酶1(Ero1)-α,Ero1β和蛋白质二硫键异构酶(PDI)通过western印迹测定心肌组织和H9c2细胞中的水平。在本研究中,糖尿病并发MI促进了ST段抬高和心肌细胞凋亡,增加了梗塞面积,诱发了病理变化,并升高了LVEDP,CK-MB,cTnT,GRP78,CHOP,Bax,Ero1α,Ero1β和PDI。但是,它降低了心率,LVSP和Bcl-2。此外,高糖结合低氧治疗降低了细胞活力,诱导了细胞周期停滞在G1期,促进了细胞凋亡,并激活了GRP78 / CHOP和Ero1 / PDI信号通路,这些通路都可以通过CHOP抑制来逆转。因此,CHOP可能是治疗并发MI的糖尿病的有效治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号